Glioblastoma Following Treated Medulloblastoma After 29 Years in the Posterior Fossa: Case Report and Review of Literature.
cerebellar neoplasm
glioblastoma
high-grade glioma
long-term effect of radiotherapy
medulloblastoma
meningioma
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2022
2022
Historique:
received:
17
08
2021
accepted:
08
03
2022
entrez:
2
5
2022
pubmed:
3
5
2022
medline:
3
5
2022
Statut:
epublish
Résumé
Glioblastoma multiforme (GBM) is a high-grade glioma that may be a rare complication of radiotherapy. We report a case of a patient who was treated for medulloblastoma (MB) of the posterior fossa at the age of 27 years. Twenty-nine years later, at the age of 56 years, he presented with a double-location tumor: supratentorial and in the posterior fossa. Imaging features of the supratentorial location were very suggestive of a meningioma. We operated on the posterior fossa location, which revealed a glioblastoma. Histologically, the tumor cells exhibited characteristics of both GBM and rhabdoid tumor cells. Literature reports of cases of GBM following MB at the same place are very rare, and presenting rhabdoid characteristics is even rarer. This is the first case of MB and GBM at ages 27 and 56 years, respectively. The double-location supratentorial probable meningioma and GBM of the posterior fossa 32 years after MB is the only case reported in the literature. What to do in this case remains a topic of debate, and there are no clear recommendations in the literature.
Identifiants
pubmed: 35494079
doi: 10.3389/fonc.2022.760011
pmc: PMC9043312
doi:
Types de publication
Case Reports
Langues
eng
Pagination
760011Informations de copyright
Copyright © 2022 Mesbahi, Zaine, Mahazou Abdou, Chekrine, Sahraoui, Karkouri and Lakhdar.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Neuropathology. 2012 Oct;32(5):543-50
pubmed: 22151431
Brain Tumor Pathol. 2010 Apr;27(1):39-43
pubmed: 20425047
Lancet. 1999 Jul 3;354(9172):34-9
pubmed: 10406363
Neurosurgery. 1980 May;6(5):546-51
pubmed: 6251397
Mol Clin Oncol. 2018 Oct;9(4):415-418
pubmed: 30233795
Neurosurg Rev. 2017 Oct;40(4):549-557
pubmed: 27159974
J Pediatr Hematol Oncol. 2010 Oct;32(7):e272-8
pubmed: 20736849
J Clin Neurosci. 2012 Dec;19(12):1627-35
pubmed: 22836037
Neuro Oncol. 2009 Oct;11(5):543-9
pubmed: 19179425
J Neurosurg. 2013 Aug;119(2):412-9
pubmed: 23641829
Hum Pathol. 2014 Mar;45(3):611-20
pubmed: 24457079
Neurosurg Focus. 2008;24(5):E7
pubmed: 18447746
Childs Nerv Syst. 2013 Oct;29(10):1865-70
pubmed: 23571774
Neuropathology. 2008 Dec;28(6):633-9
pubmed: 18384514
Radiother Oncol. 2006 Oct;81(1):33-8
pubmed: 16973227
J Neurosurg. 1978 Sep;49(3):445-9
pubmed: 682008
Br J Neurosurg. 2004 Dec;18(6):617-21
pubmed: 15799195
J Neurosurg. 1987 Dec;67(6):915-8
pubmed: 2824720
BMJ. 1992 May 23;304(6838):1343-6
pubmed: 1611331
J Neurosurg. 2005 May;102(4 Suppl):417-22
pubmed: 15926395
Nagoya J Med Sci. 2015 Feb;77(1-2):321-8
pubmed: 25797998
Childs Nerv Syst. 2011 Mar;27(3):445-53
pubmed: 21234575
Cancer Res. 1991 Dec 1;51(23 Pt 1):6393-6
pubmed: 1933904
J Neuropathol Exp Neurol. 2007 Aug;66(8):740-9
pubmed: 17882018
Brain Tumor Pathol. 2009;26(1):19-24
pubmed: 19408093
Brain Tumor Pathol. 2016 Apr;33(2):137-46
pubmed: 26667174
J Neurosurg Pediatr. 2012 Oct;10(4):281-90
pubmed: 22900483
J Natl Cancer Inst. 2006 Nov 1;98(21):1528-37
pubmed: 17077355
Childs Nerv Syst. 2004 Jan;20(1):46-9
pubmed: 14714135
Cancer. 1998 Jan 1;82(1):8-34
pubmed: 9428476
Sci Rep. 2020 Jun 10;10(1):9371
pubmed: 32523021
Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1381-7
pubmed: 18262733
Br J Neurosurg. 1995;9(5):629-37
pubmed: 8561935
Neurol Med Chir (Tokyo). 2011;51(6):449-54
pubmed: 21701112